Search results
Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab (Revised)
Zacks via Yahoo Finance· 3 hours agoIf Eli Lilly's (LLY) donanemab is approved by the FDA, it will become the second drug approved by...
Cim Investment Management Inc. Trims Position in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 10 hours agoCim Investment Management Inc. decreased its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 4.2% in the fourth quarter, according to its most recent Form 13F filing ...
Biogen (BIIB) & Eisai's Leqembi sBLA Gets FDA Acceptance
Zacks via Yahoo Finance· 4 days agoFDA accepts Biogen's (BIIB) partner Eisai's sBLA for a maintenance intravenous dosing version of...
Biogen Inc. (NASDAQ:BIIB) Stock Position Trimmed by Stephens Inc. AR
ETF DAILY NEWS· 5 days agoStephens Inc. AR cut its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 2.8% during the 4th quarter, according to the company in its most recent filing with the Securities ...
Gabelli Funds LLC Has $3.80 Million Stock Position in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 5 days agoGabelli Funds LLC trimmed its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 0.5% during the fourth quarter, according to its most recent disclosure with the ...
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit
Morningstar· 4 days agoThe Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Biogen Inc. ("Biogen" or the "Company ...
Biogen Inc. (NASDAQ:BIIB) Shares Sold by Crossmark Global Holdings Inc.
ETF DAILY NEWS· 6 days agoCrossmark Global Holdings Inc. decreased its position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 19.1% during the 4th quarter, HoldingsChannel reports. The institutional ...
BIOGEN INC. (NASDAQ: BIIB) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class...
Morningstar· 4 days agoDo you, or did you, own shares of Biogen Inc. (NASDAQ: BIIB)? Did you lose money in your investment in Biogen Inc.? Bernstein Liebhard LLP announces that a securities class ...
FDA panel votes unanimously for Eli Lilly's Alzheimer's treatment
Yahoo Finance· 4 days agoLilly's results showed a 35% reduction in progress of the disease in 18 months. The only other drug...
...A Securities Fraud Class Action Lawsuit Has Been Filed Against (BIIB) - Contact Kessler Topaz...
Morningstar· 7 days agoThe law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District ...